These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 27894399

  • 1. Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Wang XT, Li P, Xu TS, Ding R, Zhang X, Bi LQ.
    Cell Mol Biol (Noisy-le-grand); 2016 Oct 31; 62(12):44-50. PubMed ID: 27894399
    [Abstract] [Full Text] [Related]

  • 2. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
    Arthritis Rheum; 2004 Dec 31; 50(12):3831-43. PubMed ID: 15593184
    [Abstract] [Full Text] [Related]

  • 3. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY, Li X, Lei YM, Xia LP, Lu J, Shen H.
    Eur Cytokine Netw; 2019 Jun 01; 30(2):67-73. PubMed ID: 31486401
    [Abstract] [Full Text] [Related]

  • 4. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
    Niu HQ, Zhao WP, Zhao XC, Luo J, Qin KL, Chen KL, Li XF.
    Int Immunopharmacol; 2018 Aug 01; 61():45-53. PubMed ID: 29803913
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.
    Li Y, Li D, Li Y, Wu S, Jiang S, Lin T, Xia L, Shen H, Lu J.
    Osteoporos Int; 2016 Apr 01; 27(4):1537-1546. PubMed ID: 26572759
    [Abstract] [Full Text] [Related]

  • 6. Effects of iguratimod on the levels of circulating regulators of bone remodeling and bone remodeling markers in patients with rheumatoid arthritis.
    Wang X, Ma C, Li P, Zhao F, Bi L.
    Clin Rheumatol; 2017 Jun 01; 36(6):1369-1377. PubMed ID: 28474138
    [Abstract] [Full Text] [Related]

  • 7. Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.
    Ainola M, Mandelin J, Liljeström M, Konttinen YT, Salo J.
    Clin Exp Rheumatol; 2008 Jun 01; 26(2):240-6. PubMed ID: 18565244
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis.
    Gao QF, Zhang XH, Yuan FL, Zhao MD, Li X.
    Cell Biol Int; 2016 Dec 01; 40(12):1340-1348. PubMed ID: 27730697
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients.
    Wei Y, Sun X, Hua M, Tan W, Wang F, Zhang M.
    Biomed Res Int; 2015 Dec 01; 2015():214683. PubMed ID: 26273599
    [Abstract] [Full Text] [Related]

  • 10. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
    Wang Z, Ding L, Zhang S, Jiang T, Yang Y, Li R.
    Int J Mol Med; 2014 Dec 01; 34(6):1720-6. PubMed ID: 25270538
    [Abstract] [Full Text] [Related]

  • 11. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.
    Arthritis Res Ther; 2015 Feb 17; 17(1):31. PubMed ID: 25811130
    [Abstract] [Full Text] [Related]

  • 12. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
    Sun Y, Yao Y, Ding CZ.
    Int Immunopharmacol; 2014 Jan 17; 18(1):135-41. PubMed ID: 24287449
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Wen H, Liu Y, Li J, Wei D, Liu D, Zhao F.
    Clin Exp Rheumatol; 2018 Jan 17; 36(5):798-805. PubMed ID: 29465363
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-13 reduces bone erosion in rheumatoid arthritis by up-regulating osteoprotegerin expression in fibroblast-like synoviocytes : an in vitro and in vivo study.
    Chen Z, Cheng Z, Tang Z, Li M, Tang X, Zhang H, Sun L.
    Clin Exp Rheumatol; 2023 Nov 17; 41(11):2151-2161. PubMed ID: 36995338
    [Abstract] [Full Text] [Related]

  • 15. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption.
    Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT.
    Arthritis Rheum; 2008 Aug 17; 58(8):2397-408. PubMed ID: 18668542
    [Abstract] [Full Text] [Related]

  • 16. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.
    Yao Y, Ding CZ, Fang Y.
    Rheumatol Int; 2013 Jul 17; 33(7):1845-53. PubMed ID: 23334376
    [Abstract] [Full Text] [Related]

  • 17. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
    Revu S, Neregård P, af Klint E, Korotkova M, Catrina AI.
    Arthritis Res Ther; 2013 Jul 17; 15(6):R205. PubMed ID: 24295447
    [Abstract] [Full Text] [Related]

  • 18. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
    Hashizume M, Hayakawa N, Mihara M.
    Rheumatology (Oxford); 2008 Nov 17; 47(11):1635-40. PubMed ID: 18786965
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate inhibits effects of platelet-derived growth factor and interleukin-1β on rheumatoid arthritis fibroblast-like synoviocytes.
    Bergström B, Carlsten H, Ekwall AH.
    Arthritis Res Ther; 2018 Mar 20; 20(1):49. PubMed ID: 29554943
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.
    Świerkot J, Gruszecka K, Matuszewska A, Wiland P.
    Arch Immunol Ther Exp (Warsz); 2015 Oct 20; 63(5):397-404. PubMed ID: 25837853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.